Table 1.
Demographic characteristics of all subjects with airway mycosis and asthma
| Numbers (N) | All (50) | Treated never smokers (26) | Treated ever smokers (15) | Untreated (9) |
|---|---|---|---|---|
| Age ± SD | 59 ± 14 | 54 ± 18 | 61 ± 9 | 60 ± 15 |
| Males (%) | 40 (77) | 20 (77) | 15 (88) | 5 (56) |
| FEV1 % predicted ± SD | 71 ± 20 | 68 ± 22 | 71 ± 16 | 78 ± 21 |
| FVC % predicted ± SD | 69 ± 10 | 69 ± 11 | 69 ± 8 | 70 ± 6 |
| Smoking, N (PPY ± SD) | ||||
| Total | 18 (37 ± 20) | 0 (N/A) | 15 (38 ± 22) | 3 (32 ± 13) |
| Active | 4 (47.5 ± 25) | 0 (N/A) | 4 (47.5 ± 25) | 0 (N/A) |
| Former | 14 (34 ± 19) | 0 (N/A) | 11 (35 ± 21) | 3 (32 ± 13) |
| Never | 26 (N/A) | 0 (N/A) | 0 (N/A) | 0 (N/A) |
| Asthma | 50 | 26 | 15 | 9 |
| COPD (%) | 13 (25) | 1 (0.04) a | 7 (41) | 5 (56) |
| Inhaled Steroid (%) | 52 (100) | 26 (100) | 15 (100) | 9 (100) |
| Oral Steroid (%) | 41 (78) | 20 (77) | 14 (93) | 7 (78) |
a
Reported second hand smoke exposure.